Biochemistry Core

Home Services Core Facilities Biochemistry Core
Print

Helping Researchers Use BioID & More

The Biochemistry Core provides a centralized resource of expertise, equipment and technical capabilities that cover a variety of methods in the separation and analysis of complex biological samples. These capabilities include the BioID method to screen for protein-protein interactions, multi-analyte detection and quantification of proteins and lipid analysis by GC/MS.

The Biochemistry Core is supported by the Center for Pediatric Research (NIGMS CoBRE P30GM154633).

We’ve answered the most common questions about BioID in the section below titled “Frequently Asked Questions.” If you have more questions, please contact us.

COBRE Funding Acknowledgment & Foreign Component Policy

Use of COBRE-supported Core facilities is intended to support research that complies with NIH requirements for COBRE awards, including restrictions related to foreign components.

What this means for your publications:

  • COBRE support may be acknowledged only when the work is fully compliant with NIH policy
  • NIH has clarified that collaborations with investigators at foreign institutions resulting in co-authorship are considered a foreign component
  • Because foreign components are not allowable under COBRE awards, publications that include foreign co-authors should not acknowledge COBRE support

Before publishing:

  • Confirm that COBRE funding can be appropriately attributed to your work
  • If you are unsure, please contact the Tracey McMahon prior to submission: Tracey.McMahon@sanfordhealth.org  

COBRE Core facilities do not determine authorship decisions; however, it is the responsibility of the investigator to ensure that acknowledgment of COBRE support is appropriate and compliant with NIH policy.

For full details, please refer to the COBRE Foreign Component Policy

Learn More

Services

BioID is a new method to screen for candidate protein-protein interactions based on proximity-dependent biotinylation BioID Resources.

The core will provide assistance with:

  • Project design
  • Testing of BioID-fusion proteins
  • Establishment and testing of cells expressing bioid-fusion proteins
  • Large scale BioID pull-downs
  • Arranging for candidate identification by mass spectrometry
  • Data analysis

 

In addition to BioID, the Core will also provide assistance with BioID-derivatives including TurboID.

Equipment

 
  • Agilent 7890A Gas Chromatograph System
  • Agilent 5977B Mass Spectrometry System
  • Luminex 200 Multiplex Protein Analysis System
  • Nicoya OpenSPR (surface plasmon resonance)
  • Bio-Rad ChemiDoc MP Imager
  • LiCor Odyssey Fc Imager
  • BioTek Cytation 3 Cell Imaging Multi-Mode Reader

Publications

About BioID

BioID is a method to screen for proximate and interacting proteins in living cells. This is accomplished by fusion of a promiscuous biotin ligase (we call it BirA*) to a protein of interest (a bait) for expression in live cells. Addition of excess biotin leads to efficient biotinyation of endogenous proteins adjacent to/interacting with the bait. These biotinylated proteins (called candidates) can be monitored by fluorescence microscopy or Western blot analysis and isolated for identification by mass spectrometry. The biological relevance of the candidates to the bait can be subsequently validated by a variety of conventional approaches.

Meet Our Team

Kyle Roux, PhD

Director

Through his research, Dr. Kyle Roux seeks to understand the structure and function of the nuclear envelope in health and disease, and to further develop the BioID method. His work, along with other research groups, gave rise to the LINC-complex model, a structure that spans the nuclear envelope and links the nucleoskeleton to the cytoskeleton. He also investigated the post-translational processing of lamin-A, a major constituent of the nuclear lamina, both in a mouse model for Hutchinson-Gilford Progeria Syndrome, and in relation to protease and farnesyltransferase inhibitors.

Danielle May, MS

Core Manager

Danielle May received her B.S. in physiology and neuroscience from the University of California-San Diego and continued her work there to earn an M.S. in biology. She then worked at the Scripps Research Institute in La Jolla, California, learning mass spectrometry and proteomics in the Yates Lab before joining the Biochemistry Core.

Rachel Chrisopulos

Research Specialist

Rachel Chrisopulos received her B.S. in biology with a specialization in molecular biology and physiology from the University of South Dakota. She then worked as a pesticide residue chemist at SGS in Brookings, South Dakota, for five years, working extensively with LC-MS/MS and GC-MS instrumentation before joining the Biochemistry Core.

Frequently Asked Questions

How do I get the biotin to go into solution in the cell media?

We make a 20X stock solution (1mM) of biotin (Sigma cat# B4639) in our standard tissue culture media (without serum) and use it at 1X (50uM, with serum). This 20X solution is filter sterilized and is stable at 4 deg C for at least a couple of months.

Do I have to regulate inducibly regulate expression of my BioID fusion protein?

As a rule, no. We have generated many stable cell lines that constitutively express a variety of BioID fusion proteins and utilized these for large-scale BioID pull-downs. The most effective method to regulate biotinylation by BioID is the addition of excess biotin to cell culture media. However, in some circumstances it may be ideal and/or necessary to inducibly express a BioID-fusion protein, for example if the protein is toxic.  Inducible regulation of fusion-protein expression is highly recommended when utilizing the TurboID ligase.

Do I need to express a lot of BioID-fusion protein to identify interaction candidates?

In our experience, no. Although more fusion protein can equal more biotinylation of endogenous proteins, we are able to obtain a large number of uniquely biotinylated proteins (defined as those not detected in parallel pull-downs from control cells) from cells stably expressing BioID-fusion proteins in which we can barely detect the protein by immunofluorescence.

What is the effective range of biotinylation by BioID?

Please see our manuscript on this topic: Kim DI, KC B, Zhu W, Motamedchaboki K, Doye V, Roux KJ. Probing nuclear pore complex architecture with proximity-dependent biotinylation. Proc Natl Acad Sci USA. 2014 Jun 17;111(24):E2453-61. Pubmed PMID: 24927568


Sanford Health News

View All News